Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31 - PubMed (original) (raw)
Comparative Study
Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31
S Lee-Huang et al. Proc Natl Acad Sci U S A. 1995.
Abstract
MAP30 (Momordica anti-HIV protein of 30 kDa) and GAP31 (Gelonium anti-HIV protein of 31 kDa) are anti-HIV plant proteins that we have identified, purified, and cloned from the medicinal plants Momordica charantia and Gelonium multiflorum. These antiviral agents are capable of inhibiting infection of HIV type 1 (HIV-1) in T lymphocytes and monocytes as well as replication of the virus in already-infected cells. They are not toxic to normal uninfected cells because they are unable to enter healthy cells. MAP30 and GAP31 also possess an N-glycosidase activity on 28S ribosomal RNA and a topological activity on plasmid and viral DNAs including HIV-1 long terminal repeats (LTRs). LTRs are essential sites for integration of viral DNA into the host genome by viral integrase. We therefore investigated the effect of MAP30 and GAP31 on HIV-1 integrase. We report that both of these antiviral agents exhibit dose-dependent inhibition of HIV-1 integrase. Inhibition was observed in all of the three specific reactions catalyzed by the integrase, namely, 3' processing (specific cleavage of the dinucleotide GT from the viral substrate), strand transfer (integration), and "disintegration" (the reversal of strand transfer). Inhibition was studied by using oligonucleotide substrates with sequences corresponding to the U3 and U5 regions of HIV LTR. In the presence of 20 ng of viral substrate, 50 ng of target substrate, and 4 microM integrase, total inhibition was achieved at equimolar concentrations of the integrase and the antiviral proteins, with EC50 values of about 1 microM. Integration of viral DNA into the host chromosome is a vital step in the replicative cycle of retroviruses, including the AIDS virus. The inhibition of HIV-1 integrase by MAP30 and GAP31 suggests that impediment of viral DNA integration may play a key role in the anti-HIV activity of these plant proteins.
Similar articles
- Human immunodeficiency virus type 1 (HIV-1) inhibition, DNA-binding, RNA-binding, and ribosome inactivation activities in the N-terminal segments of the plant anti-HIV protein GAP31.
Lee-Huang S, Kung HF, Huang PL, Bourinbaiar AS, Morell JL, Brown JH, Huang PL, Tsai WP, Chen AY, Huang HI, et al. Lee-Huang S, et al. Proc Natl Acad Sci U S A. 1994 Dec 6;91(25):12208-12. doi: 10.1073/pnas.91.25.12208. Proc Natl Acad Sci U S A. 1994. PMID: 7527556 Free PMC article. - Anti-HIV and anti-tumor activities of recombinant MAP30 from bitter melon.
Lee-Huang S, Huang PL, Chen HC, Huang PL, Bourinbaiar A, Huang HI, Kung HF. Lee-Huang S, et al. Gene. 1995 Aug 19;161(2):151-6. doi: 10.1016/0378-1119(95)00186-a. Gene. 1995. PMID: 7665070 - The antiviral agents, MAP30 and GAP31, are not toxic to human spermatozoa and may be useful in preventing the sexual transmission of human immunodeficiency virus type 1.
Schreiber CA, Wan L, Sun Y, Lu L, Krey LC, Lee-Huang S. Schreiber CA, et al. Fertil Steril. 1999 Oct;72(4):686-90. doi: 10.1016/s0015-0282(99)00302-7. Fertil Steril. 1999. PMID: 10521111 - Ribosome inactivating proteins (RIPs) from Momordica charantia for anti viral therapy.
Puri M, Kaur I, Kanwar RK, Gupta RC, Chauhan A, Kanwar JR. Puri M, et al. Curr Mol Med. 2009 Dec;9(9):1080-94. doi: 10.2174/156652409789839071. Curr Mol Med. 2009. PMID: 19747115 Review. - HIV-1 integration as a target for antiretroviral therapy: a review.
Pluymers W, De Clercq E, Debyser Z. Pluymers W, et al. Curr Drug Targets Infect Disord. 2001 Aug;1(2):133-49. doi: 10.2174/1568005014606044. Curr Drug Targets Infect Disord. 2001. PMID: 12455410 Review.
Cited by
- Trichosanthin inhibits integration of human immunodeficiency virus type 1 through depurinating the long-terminal repeats.
Zhao WL, Feng D, Wu J, Sui SF. Zhao WL, et al. Mol Biol Rep. 2010 Apr;37(4):2093-8. doi: 10.1007/s11033-009-9668-2. Epub 2009 Aug 11. Mol Biol Rep. 2010. PMID: 19669933 - Inhibition of HIV-1 replication by balsamin, a ribosome inactivating protein of Momordica balsamina.
Kaur I, Puri M, Ahmed Z, Blanchet FP, Mangeat B, Piguet V. Kaur I, et al. PLoS One. 2013 Sep 5;8(9):e73780. doi: 10.1371/journal.pone.0073780. eCollection 2013. PLoS One. 2013. PMID: 24040067 Free PMC article. - Genetic analysis and QTL mapping of yield and fruit traits in bitter gourd (Momordica charantia L.).
Rao PG, Behera TK, Gaikwad AB, Munshi AD, Srivastava A, Boopalakrishnan G, Vinod. Rao PG, et al. Sci Rep. 2021 Feb 18;11(1):4109. doi: 10.1038/s41598-021-83548-8. Sci Rep. 2021. PMID: 33603131 Free PMC article. - Engineering of Ribosome-inactivating Proteins for Improving Pharmacological Properties.
Lu JQ, Zhu ZN, Zheng YT, Shaw PC. Lu JQ, et al. Toxins (Basel). 2020 Mar 9;12(3):167. doi: 10.3390/toxins12030167. Toxins (Basel). 2020. PMID: 32182799 Free PMC article. Review. - An additional mechanism of ribosome-inactivating protein cytotoxicity: degradation of extrachromosomal DNA.
Nicolas E, Goodyer ID, Taraschi TF. Nicolas E, et al. Biochem J. 1997 Oct 15;327 ( Pt 2)(Pt 2):413-7. doi: 10.1042/bj3270413. Biochem J. 1997. PMID: 9359409 Free PMC article.
References
- J Virol. 1993 Mar;67(3):1169-74 - PubMed
- J Biol Chem. 1987 Jun 15;262(17):8128-30 - PubMed
- Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3428-32 - PubMed
- J Virol. 1994 Jun;68(6):3896-907 - PubMed
- Proc Natl Acad Sci U S A. 1984 Dec;81(24):7885-9 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous